Impact of a Structured Intensive Follow-up Program on the Control of Hypertension in Coronary Patients a Randomized Trial [15]

Size: px
Start display at page:

Download "Impact of a Structured Intensive Follow-up Program on the Control of Hypertension in Coronary Patients a Randomized Trial [15]"

Transcription

1 ARTIGOS ORIGINAIS CONCISOS Impact of a Structured Intensive Follow-up Program on the Control of Hypertension in Coronary Patients a Randomized Trial [15] PEDRO S. MATEUS, NUNO BETTENCOURT, CARLA COSTA DIAS, LINO SANTOS, LUÍS ADÃO, JOSÉ ROBERTO, CARLOS MATEUS, JOSÉ RIBEIRO, JOÃO PRIMO, LINO SIMÕES, VASCO GAMA RIBEIRO, HENRIQUE BARROS Cardiology Department, Vila Nova de Gaia Hospital Centre, Vila Nova de Gaia, Portugal Epidemiology Department, University of Porto, Medical School, Porto, Portugal Rev Port Cardiol 2005; 24(2): ABSTRACT Introduction: Hypertension is an important risk factor for cardiovascular events. Although several anti-hypertensive agents have shown to be effective in the treatment of hypertension, adequate blood pressure control is not frequent in most populations. The aim of this study was to evaluate the effect of a structured intensive follow-up program (SIFUP) on the control of blood pressure in coronary patients. Patients and Methods: we performed a prospective, randomized study including 237 patients admitted to the Cardiology Department for acute coronary syndrome. Patients were randomly assigned to a SIFUP (n=129) or to the general cardiology outpatient department (COD) (n=108). An experienced doctor performed a blind assessment of blood pressure in 157 randomised patients, 9 to 18 months after discharge. In statistical analysis, the chisquare test was used to compare proportions and the Student s t test to compare means. Results: Both groups were predominantly male and mean age was similar. The proportion of patients with known hypertension randomised to the SIFUP and the COD did not differ. At the 9 to 18-month assessment there was no statistical significant difference in the proportion of patients with blood pressure under target values (57.5% in SIFUP and 48.5% in COD, p=ns). However, in hypertensive patients, the proportion of controlled patients was significantly higher in the SIFUP than in the COD (44.8% vs. 24.2%, p=0.05) and systolic and mean blood RESUMO Impacto de um Programa Estruturado de Seguimento Intensivo no Controlo da Hipertensão em Doentes Coronários um Ensaio Randomizado Introdução: A hipertensão arterial é um importante factor de risco para eventos cardiovasculares. Embora existam variados fármacos eficazes no tratamento da hipertensão, verifica-se um controlo inadequdo da pressão arterial na maioria das populações. O objectivo deste estudo foi avaliar o impacto de um Programa Estruturado de Seguimento Intensivo (PESI) no controlo da pressão arterial em doentes coronários. Pacientes e Métodos: Foi efectuado um estudo prospectivo, aleatorizado, incluindo 237 doentes internados no Serviço de Cardiologia por Síndrome Coronário Agudo. Na data de alta, os doentes foram referenciados, de forma aleatória, ao PESI (n = 129) ou à Consulta Externa de Cardiologia (CEC) (n = 108). Um médico efectuou a avaliação da pressão arterial entre 9 e 18 meses após a alta hospitalar em 157 pacientes, com ocultação para o resultado da aleatorização. Foi utilizado o teste do qui-quadrado na comparação de proporções e o teste t de Student na comparação de variáveis contínuas. Resultados: Verificou-se, nos dois grupos, uma proporção mais elevada de doentes do sexo masculino; não foram encontradas diferenças na média etária. A proporção de doentes com hipertensão arterial conhecida não foi significativamente diferente entre o 223 Recebido para publicação: Agosto de 2004 Aceite para publicação: Novembro de 2004 Received for publication: August 2004 Accepted for publication: November 2004

2 Rev Port Cardiol Vol. 24 Fevereiro 05/ February 05 pressure were significantly lower in the SIFUP (respectively vs mmhg, p=0.04 and 98.7 vs mmhg, p=0.03); diastolic blood pressure was also lower in SIFUP (78.5 vs mmhg, p=ns). Conclusions: The SIFUP has shown to be effective in lowering blood pressure in hypertensive coronary patients. The proportion of patients with controlled blood pressure was consistently higher in the SIFUP. PESI e a CEC. Na avaliação efectuada entre os 9 e 18 meses após a alta, não foram demonstradas diferenças estatisticamente significativas na proporção de doentes com valores de pressão arterial inferiores aos recomendados (57,5 % no PESI e 48,5 % na CEC, p = ns). No entanto, considerando apenas os doentes com hipertensão conhecida, a proporção de doentes com pressão arterial controlada foi significativamente mais elevada no PESI do que na CEC (44,8 % vs 24,2 %, p= 0,05) e a pressão arterial sistólica e média foi também significativamente menor no PESI do que na CEC (respectivamente 139,0 vs 148,8 mmhg, p = 0,04 e 98,7 vs 103,9 mmhg, p = 0,03); a pressão arterial diastólica foi também menor no PESI (78,5 vs 81,5 mmhg, p = ns). Conclusões: O PESI demonstrou ser eficaz na obtenção de uma redução adicional da pressão arterial em doentes coronários com hipertensão. A proporção de doentes com pressão arterial controlada foi consistentemente mais elevada no PESI. Key wordse Hypertension; Blood pressure; Myocardial infarction; Unstable angina; Follow-up; Randomized trial Palavras-chave Hipertensão; Pressão arterial; Enfarte do miocárdio; Angina instável; Seguimento; Ensaio randomizado 224 INTRODUCTION Hypertension is an important risk factor for cardiovascular events; several trials of anti-hypertensive agents have shown that treatment of hypertension reduces the morbidity and mortality associated with high blood pressure (1, 2). Nevertheless, adequate blood pressure control is poor in most populations; the best results have been reported in the United States of America, indicating that only about 34% of hypertensive patients were controlled in (3). In European countries, the proportion of patients with properly controlled blood pressure was even lower (4, 5). Moreover, the treatment goals recommended by recent guidelines are increasingly strict, particularly in patients with diabetes or renal disease (3, 6). Patients with high cardiovascular risk, such as those who have suffered an acute coronary syndrome, are also an important population that needs intensive management of high blood pressure. International scientific societies have provided guidelines about life-style modification and pharmacological treatment of arterial hypertension, but little attention has been given to the patient s follow-up methods. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends that follow-up should be performed on a monthly basis until blood pressure control is achieved, and thereafter one follow-up visit every 3 to 6 months should be adequate (3). The British Society of Hypertension and Canadian consensus guidelines suggest similar follow-up periods. However, these recommendations are only based on non-controlled studies and there is a clear absence of evidence that different intervals and methods of follow-up could influence blood pressure control. The Cardiology Department of The Vila Nova de Gaia Hospital Centre has set up a Structured Intensive Follow-up Program of patients admitted in this department for acute coronary syndrome, to improve control of cardiovascular risk factors and achieve better long-term results in this high-risk population.

3 So, the aim of present study was to evaluate, in these patients, the effectiveness of this Intensive Follow-up Program in the long-term control of blood pressure, in comparison with standard care in the outpatient department. METHODS The study was conducted in the Cardiology Department of the Vila Nova de Gaia Hospital Center. Recruitment of patients began after approval of the research protocol by the institution s Ethics Committee. Informed consent was obtained from patients enrolled in the study. Study Population Patients admitted for acute coronary syndrome to the Cardiology Department between July 2001 and December 2002 were eligible to participate in the study. Exclusion criteria were previous follow-up in a cardiology or internal medicine clinic, even in the same hospital, in-hospital fatal myocardial infarction or significant non-cardiovascular comorbidity that precluded a 9 to 18-month follow-up. Patients could not be excluded on the basis of age or gender. In this period, 509 patients were admitted to the Cardiology Department for acute coronary syndrome. At hospital discharge, 237 patients were enrolled in the study. Randomization Patients enrolled in the study were randomly assigned to a structured intensive follow-up program (SIFUP 129 patients) or referred for usual follow-up in the cardiology outpatient department (COD 108 patients). Two patients (one from each group) decided after randomization to have their follow-up visits in another cardiology clinic and were therefore excluded from the data analysis. PEDRO S. MATEUS, et al Rev Port Cardiol 2005; 24: In the COD group, the frequency of appointments, diagnostic procedures and prescription of treatments was left entirely at the consulting cardiologist s discretion. Psychiatric counseling was available for SI- FUP patients and appointments with a nutritionist were possible in both groups. Outcome assessment A clinical examination, performed by a doctor with experience in cardiology, blinded to the randomization result, was planned for 9 to 18 months after hospital discharge. The objectives of this assessment were evaluation of cardiovascular symptoms, of physical examination signs and compliance with treatment. During this clinical evaluation, blood pressure measurement with a mercury sphygmomanometer was performed twice, in the sitting position, after 5 minutes of rest. An interval of 5 minutes or more was observed between the first and the second measurement. An adequate evaluation of blood pressure was possible in 157 patients. Mean blood pressure was computed using the formula (2x diastolic blood pressure+systolic blood pressure)/3. The mean of the two measurements of systolic and diastolic blood pressure was used in the data analysis. Normal and target blood pressure values for hypertensive patients were defined according to the most recent recommendations of the European Society of Hypertension (6). Blood pressure control was considered adequate when blood pressure was lower than 140/90 mmhg in nondiabetic patients and below 130/80 mmhg in patients with diabetes. Statistical analysis Statistical analysis was performed using SPSS for Windows. In the comparison of means between SIFUP and COD the Student s t test was used. The proportions of patients with normal values and controlled blood pressure were computed and the chi-square test was used to compare proportions. Follow-up groups The SIFUP consisted of pre-determined appointments at 1 week after discharge and thereafter at 1, 3, 6, 9 and 12 months. At 3 and 12 months after discharge an echocardiogram and laboratory studies were to be performed in all patients and an exercise stress test in patients able to exercise. Non-programmed visits could be dictated by medical reasons other than control of blood pressure. RESULTS The baseline characteristics of patients randomized to each group with available blood pressure measurements in follow-up are presented in Table I. A past history of hypertension 225

4 Rev Port Cardiol Vol. 24 Fevereiro 05/ February 05 Table 1 Baseline characteristics of randomized patients with available follow-up blood pressure evaluation. SIFUP COD n=89 N=68 p Sex Male n (%) 63 (70.8) 49 (72.1) 0.86 Age mean ( SD) 60.8 (12.7) 60.8 (11.2) 0.96 Previous risk factors Hypertension n (%) 58 (61.1) 37 (54.7) 0.14 Diabetes n (%) 20 (22.7) 21 (30.9) 0.25 Hypercholesterolemia n (%) 52 (59.1) 37 (54.4) 0.56 Current smokingn (%) 30 (34.1) 27 (40.3) 0.29 Previous cardiovascular events* n (%) 29 (33.0) 17 (25.0) 0.16 Discharge diagnosis Unstable angina n (%) 18 (20.2) 11 (16.2) Non-Q wave MI n (%) 38 (42.7) 26 (38.2) Q-wave MI n (%) 33 (37.0) 31 (45.6) 0.54 * Previous hospital admission for acute coronary syndrome, percutaneous coronary intervention, coronary artery bypass graft or stroke. MI: Myocardial infarction. was frequent in both groups and the proportion of hypertensive patients was higher in the SI- FUP group. No significant differences were found in baseline characteristics between groups. The proportion of patients with normal blood pressure values was higher in the SIFUP than in the COD group (respectively 57.5% and 48.5%, p=ns). Adequate blood pressure control was achieved in a minority of hypertensive patients. In SIFUP 26 (44.8%) patients with past history of hypertension had controlled blood pressure and in the COD group only 8 (24.2%) patients achieved the target blood pressure (p=0.05). No differences were found between the SI- FUP and COD groups in systolic, mean or diastolic blood pressure in the overall study po- pulation. However, considering only hypertensive patients, systolic and mean blood pressure were significantly higher in the COD group (Fig. 1). Although not statistically significant, diastolic blood pressure was higher in the COD group as well. Pulse pressure was higher in patients randomized to the COD group (62.7mmHg) than in patients following the SIFUP (56.7 mmhg, p=0.06). Adjusting for diastolic BP, pulse pressure was 6.0 mmhg lower in the SIFUP group in all patients (p=0.06) and 7.8 mmhg in hypertensive patients (p=0.08). A higher number of anti-hypertensive agents were used in the SIFUP (mean 2.2 drugs per patient versus 1.8 in the COD group, p=0.004). DISCUSSION This study shows that different methods of follow-up have different results in blood pressure control. Use of structured intensive programs could increase the number of controlled patients, in comparison with appointments at the cardiologist s discretion. An additional effort was made to obtain unbiased and accurate estimates of blood pressure levels in each patient. Blood pressure measurements were performed by an experienced observer, not aware of randomization status. Two measurements of blood pressure were taken in each clinical evaluation to obtain a more reliable estimate of patients usual values. However, a significant number of randomized patients could not have a blinded evaluation, because some patients were unable to come to the hospital for an extra examination outside of their programmed appointments, for personal or employment-related reasons. Other patients moved away from their previous address and so contact was lost. This limitation 226 Fig. 1 Systolic, mean and diastolic blood pressure of hypertensive subjects randomized to SIFUP and COD.

5 PEDRO S. MATEUS, et al Rev Port Cardiol 2005; 24: could lead, to some degree, to a biased result. However, the response rate was similar in the two groups and no differences were found in baseline characteristics between patients who were evaluated and those who were not. The difference found between the two groups was partially due to the higher number of anti-hypertensive agents that patients in the SIFUP reported using. Nevertheless, it is likely that a structured program with a higher number of follow-up visits would improved compliance with anti-hypertensive therapy and increased patients motivation for life-style modification, thus leading to better results from therapy. A recent trial comparing follow-up of hypertensive patients either every three months or every six months found no differences between the two time intervals (7). However, this trial was conducted in a primary care setting and in stabilized hypertensive patients. Our study suggests that in a high cardiovascular risk population admitted for acute coronary syndrome, implementation of a SIFUP could improve longterm blood pressure control. Control of blood pressure was poor in both groups. We should consider, however, that these patients probably had more severe hypertension and were more frequently diabetic than the general population or unselected hypertensive patients. The reduction of blood pressure was more noticeable in systolic blood pressure than in diastolic blood pressure. This finding is consistent with other reports of population-based studies, reflecting easier and more frequent control of diastolic blood pressure. Systolic blood pressure was lowered by about 10 mmhg in the hypertensive patients in the SIFUP, compared to the COD group. This additional reduction in blood pressures levels is clinically significant and could lead to a better long-term prognosis, by reducing recurrent coronary or cerebrovascular events. As patients in SIFUP had more visits to the hospital and used more anti-hypertensive drugs, a cost-effectiveness analysis should be performed to confirm the advantages of such a program. ACKNOWLEDGEMENT This study was supported by a grant from Comissão de Fomento da Investigação em Cuidados de Saúde, Ministry of Health, P.I. no. 16/01. REFERENCES 1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood Pressure, stroke and coronary heart disease. Part 2, Short-term reductions in blood pressure: over-view of randomised drug trials in their epidemiological context. Lancet 1990;335: Dalhöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-hypertension). Lancet 1991;338: Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. JAMA 2003;289(19): Charpentier G, Genes N, Vaur L, Amar J, Clerson P, Cambou JP, Gueret P; ESPOIR Diabetes Study Investigators. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab. 2003;29(2 Pt 1): Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43(1): Guidelines Committee European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003,21: Birtwhistle RV, Godwin MS, Delva MD, Casson RI, Lam M, MacDonald S et al. Randomised equivalence trial comparing three month and six month follow-up of patients with hypertension by family practitioners. BMJ 2004;328 (7433): CONCLUSIONS The proportion of patients with controlled Pedidos de separatas para: BP was consistently higher in the SIFUP. Pulse Address for reprints: pressure was also reduced in SIFUP patients. PEDRO S. MATEUS The SIFUP has shown to be effective in lowering blood pressure in hypertensive coronary Centro Hospitalar de Vila Nova de Gaia Serviço de Cardiologia patients and the observed reduction in blood VILA NOVA DE GAIA pressure appears to be clinically significant. PORTUGAL 227

Corporate Medical Policy Ambulatory Blood Pressure Monitoring

Corporate Medical Policy Ambulatory Blood Pressure Monitoring Corporate Medical Policy Ambulatory Blood Pressure Monitoring File Name: Origination: Last CAP Review: Next CAP Review: Last Review: ambulatory_blood_pressure_monitoring 7/1982 4/2016 4/2017 4/2016 Description

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

HOTLINE 1 O doente está primeiro! A Plataforma de Dados na Saúde e o Registo Nacional de Cardiologia de Intervenção.

HOTLINE 1 O doente está primeiro! A Plataforma de Dados na Saúde e o Registo Nacional de Cardiologia de Intervenção. HOTLINE 1 O doente está primeiro! A Plataforma de Dados na Saúde e o Registo Nacional de Cardiologia de Intervenção. Epidemiologia da doença cardíaca. O contributo dos registos observacionais. Carla Araújo

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

The practice of lowering blood pressure (BP)

The practice of lowering blood pressure (BP) Original Paper Treatment of Hypertension in the Inpatient Setting: Use of Intravenous Labetalol and Hydralazine Alan B. Weder, MD; 1 Steven Erickson, PharmD 2 Acute blood pressure elevations are commonly

More information

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE To be completed by Staff Cardiologists at an adult cardiac institute/department. INSTRUCTIONS:

More information

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit

Summary Evaluation of the Medicare Lifestyle Modification Program Demonstration and the Medicare Cardiac Rehabilitation Benefit The Centers for Medicare & Medicaid Services' Office of Research, Development, and Information (ORDI) strives to make information available to all. Nevertheless, portions of our files including charts,

More information

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS. - Summary

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS. - Summary UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL SCHOOL DOCTORATE THESIS - Summary CHRONIC COMPLICATIONS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS - Epidemiological study - PhD Manager: Professor PhD.

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Protocol. Cardiac Rehabilitation in the Outpatient Setting Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10. FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.1056/NEJMSA1107913 Niteesh K. Choudhry, MD, PhD, 1 Jerry Avorn, MD, 1 Robert J. Glynn,

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

The Canadian Association of Cardiac

The Canadian Association of Cardiac Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a

More information

Utilization Review Cardiac Rehabilitation Services: Underutilized

Utilization Review Cardiac Rehabilitation Services: Underutilized Utilization Review Cardiac Rehabilitation Services: Underutilized William J. Gill, MD Krannert Institute of Cardiology Indiana University School of Medicine Indianapolis, Indiana What is Cardiac Rehab?

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

KIH Cardiac Rehabilitation Program

KIH Cardiac Rehabilitation Program KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to

More information

Remote Delivery of Cardiac Rehabilitation

Remote Delivery of Cardiac Rehabilitation Remote Delivery of Cardiac Rehabilitation Bonnie Wakefield, RN, PhD Kariann Drwal, MS Melody Scherubel, RN Thomas Klobucar, PhD Skyler Johnson, MS Peter Kaboli, MD, MS VA Rural Health Resource Center Central

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

EMR Tutorial Acute Coronary Syndrome

EMR Tutorial Acute Coronary Syndrome EMR Tutorial Acute Coronary Syndrome How to find the Acute Coronary Syndrome AAA Home Page 1 of 26 Master Tool Bar Icon When the Template button is clicked you will be presented with the preference list.

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust Post-MI Cardiac Rehabilitation Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust 'the sum of activities required to influence favourably the underlying

More information

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 March 7, 2014 Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Dear Sir or Madam: On behalf of the American Heart Association (AHA), including the American Stroke

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification

More information

National Post Hospital Care Project and Length of Hospitalization of Patients with Stroke 2010-2011

National Post Hospital Care Project and Length of Hospitalization of Patients with Stroke 2010-2011 National Post Hospital Care Project and Length of Hospitalization of Patients with Stroke - Rede Nacional de Cuidados Continuados e Tempo de Internamento dos Doentes com Acidente Vascular Cerebral - Catarina

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Educational Goals & Objectives

Educational Goals & Objectives Educational Goals & Objectives The Cardiology rotation will provide the resident with an understanding of cardiovascular physiology and its broad systemic manifestations. The resident will have the opportunity

More information

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines

Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell

More information

Carefully review the risks and potential, but unproven, benefits of treatment.

Carefully review the risks and potential, but unproven, benefits of treatment. Hypertension This is a consensus guideline for the pharmacological management of hypertension with frailty. This information was developed by the Dalhousie University Academic Detailing Service and the

More information

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological

More information

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources James Floyd, MD, MS Sep 17, 2015 UW Hospital Medicine Faculty Development Program Objectives Become more

More information

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney,

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, Australia Cardiac rehabilitation is an effective and safe

More information

HealthCare Partners of Nevada. Heart Failure

HealthCare Partners of Nevada. Heart Failure HealthCare Partners of Nevada Heart Failure Disease Management Program 2010 HF DISEASE MANAGEMENT PROGRAM The HealthCare Partners of Nevada (HCPNV) offers a Disease Management program for members with

More information

St Lucia Diabetes and Hypertension Screening and Disease Management Programs

St Lucia Diabetes and Hypertension Screening and Disease Management Programs St Lucia Diabetes and Hypertension Screening and Disease Management Programs Michael Graven, MD, MSc,, MPH, FAAP Health Informatics and Neonatal Pediatrics Dalhousie University Halifax, Nova Scotia CANADA

More information

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care

Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care Measure #236 (NQF 0018): Controlling High Blood Pressure National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients

More information

Pereira H, SFL 2014. Stent for Life, Portugal

Pereira H, SFL 2014. Stent for Life, Portugal Stent for Life, Portugal Stent For SFL Initiative in Portugal: Improving quality by shortening patients and system delays in Portugal Hélder Pereira, SFL Champion Albufeira, 27 April2014 Stent for Life

More information

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität

More information

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL) PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)

More information

Priority setting for research in healthcare: an application of value of. information analysis to glycoprotein IIb/IIIa antagonists in non-st elevation

Priority setting for research in healthcare: an application of value of. information analysis to glycoprotein IIb/IIIa antagonists in non-st elevation Priority setting for research in healthcare: an application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-st elevation acute coronary syndrome. Further information 1. The

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota Data Management Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota None Disclosures Objectives History of data management in medicine Review of data management

More information

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke International Task Force for Prevention Of Coronary Heart Disease Clinical management of risk factors of coronary heart disease and stroke Economic analyses of primary prevention of coronary heart disease

More information

Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada

Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada Using Clinical Registries to Create Evidence-based Health Care Policy : Experiences from Ontario, Canada April 2009 Jack V. Tu, MD PhD FRCPC CANADA RESEARCH CHAIR IN HEALTH SERVICES RESEARCH Institute

More information

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Clinical pathway concept - a key to seamless care

Clinical pathway concept - a key to seamless care SECTION 5: PATIENT SAFETY AND QUALITY ASSURANCE 1 Clinical pathway concept - a key to seamless care Audrey Janoly-Dumenil, Hôpital Edouard Herriot, CHU Lyon Marie-Camille Chaumais, Hôpital Antoine Béclère,

More information

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:

More information

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:

More information

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency London, 19 July 2007 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR

More information

Hypertension and Diabetes

Hypertension and Diabetes Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital

More information

The role of a low sodium diet in the management of hypertension. Dave Glover Consultant Nephrologist, Wrexham

The role of a low sodium diet in the management of hypertension. Dave Glover Consultant Nephrologist, Wrexham The role of a low sodium diet in the management of hypertension Dave Glover Consultant Nephrologist, Wrexham Salt Aims Is it all a bit Woman s Own / Daily Mail? Current guidelines An idea about salt What

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

The Department of Vermont Health Access Medical Policy

The Department of Vermont Health Access Medical Policy State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Success factors in Behavioral Medicine

Success factors in Behavioral Medicine Success factors in Behavioral Medicine interventions post myocardial infarction Depression Gunilla post myocardial Burell, PhD infarction Department of Public Health, Uppsala University, Sweden XIII Svenska

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Stent for Life Initiative How can we improve system delay and patients delay in STEMI Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION European Medicines Agency Pre-Authorisation Evaluation of Medicines for Human Use London, 25 September 2008 Doc. Ref. EMEA/CHMP/EWP/311890/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites:

A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites: A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites: A Population-Based Study That Will Demonstrate Issues Surrounding EHR Access and Research Brett Kissela, MD, MS Professor Vice-Chair

More information

What is the Cardiovascular Health Awareness Program?

What is the Cardiovascular Health Awareness Program? What is the Cardiovascular Health Awareness Program? 1 What is CHAP? CHAP is a community-based program that brings together local family physicians, pharmacists, volunteers, public health representatives

More information

Central Office N/A N/A

Central Office N/A N/A LCD ID Number L32688 LCD Title Cardiac Rehabilitation and Intensive Cardiac Rehabilitation Contractor s Determination Number L32688 AMA CPT/ADA CDT Copyright Statement CPT only copyright 2002-2011 American

More information

I. Current Cardiac Rehabilitation Requirements

I. Current Cardiac Rehabilitation Requirements CLIENT ADVISORY July 24, 2009 CMS Proposes Changes to Cardiac Rehabilitation Program Design and Physician Supervision Requirements The Centers for Medicare and Medicaid Services (CMS) recently published

More information

ACSM Risk Factor Identification and Risk Stratification

ACSM Risk Factor Identification and Risk Stratification Thresholds for Use With ACSM Risk Stratification (p 24G) ACSM Risk Factor Identification and Risk Stratification By Dr. Sue Beckham, Ph.D., RCEP, PD Positive Family History Cigarette Smoking Myocardial

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening

More information

Outpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References)

Outpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References) CARDIAC The delivery of Cardiac Rehab is unlike most other rehab populations. The vast majority of patients receive their rehab in outpatient or community settings and only a small subset requires an inpatient

More information

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die

More information

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE

ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.

More information

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <...

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <... National Clinical Guideline Centre Draft for consultation Preoperative tests Routine preoperative tests for elective surgery Clinical guideline Appendix N: Research recommendations October 2015 Draft

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Rev Saúde Pública 2003;37(5):603-8 www.fsp.usp.br/rsp

Rev Saúde Pública 2003;37(5):603-8 www.fsp.usp.br/rsp Rev Saúde Pública 2003;37(5):603-8 603 Association between child-care and acute diarrhea: a study in Portuguese children Associação entre cuidados infantis e diarréia aguda em crianças portuguesas Henrique

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D.

Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel. Kiyuk Chang, M.D., Ph.D. Platelet Function Testing vs Genotyping : Focus on Pharmacogenomics of Clopidogrel Kiyuk Chang, M.D., Ph.D. Cardiovascular Center & Cardiology Division Seoul St. Mary s Hospital The Catholic University

More information

The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department

The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department Simbo Chiadika LAY ABSTRACT A. Study purpose Cardiac stress testing has been recommended

More information

Office ID Location: City State Date / / PRIMARY CARE SURVEY

Office ID Location: City State Date / / PRIMARY CARE SURVEY A. Organizational Characteristics PRIMARY CARE SURVEY We want to learn more about the general features of your office. A1. What health-related services does your office provide (check all that apply)?

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

- 103-7. CIGARETTE USE COUNSELING Steven Asch, M.D., M.P.H.

- 103-7. CIGARETTE USE COUNSELING Steven Asch, M.D., M.P.H. - 103-7. CIGARETTE USE COUNSELING Steven Asch, M.D., M.P.H. We relied on Chapter 48 of the Guide to Clinical Preventive Services published by the U.S. Preventive Services Task Force (USPSTF, 1989) to construct

More information

R Collins. S MacMahon

R Collins. S MacMahon British Medical Bulletin (1994) \ U 50, No 2, pp. 272-298 OThe British Council 1994 Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease R Collins MRC/ICRF

More information